53.8K(top 1%)
articles
1.2M(top 1%)
citations
7,826(top 1%)
★★ articles
487(top 1%)
★★★ articles
3.2(top 11%)
Avg IF
305(top 1%)
H-Index
572(top 1%)
G-Index
4,521
journals

Most Cited Articles of Peking Union Medical College in 2020

TitleJournalYearCitations
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaLancet, The202025.2K
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyLancet, The202015K
A novel coronavirus outbreak of global health concernLancet, The20203.7K
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialLancet, The20202.1K
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoVNature Communications20201.8K
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in ChinaCell Host and Microbe20201.3K
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injuryScience China Life Sciences20201.2K
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)Clinical Infectious Diseases2020986
On the origin and continuing evolution of SARS-CoV-2National Science Review2020868
Development of an inactivated vaccine candidate for SARS-CoV-2Science2020823
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B CellsCell2020806
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from ChinaClinical Immunology2020787
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical TrialJAMA - Journal of the American Medical Association2020755
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionCell Research2020745
The pathogenicity of SARS-CoV-2 in hACE2 transgenic miceNature2020680
SARS-CoV-2 and viral sepsis: observations and hypothesesLancet, The2020646
Transplantation of ACE2 Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia2020644
Proteomic and Metabolomic Characterization of COVID-19 Patient SeraCell2020620
Understanding of COVID-19 based on current evidenceJournal of Medical Virology2020493
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumoniaEmerging Microbes and Infections2020490
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in ChinaJournal of Autoimmunity2020467
Activation and evasion of type I interferon responses by SARS-CoV-2Nature Communications2020442
COVID-19 control in China during mass population movements at New YearLancet, The2020441
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacyScience2020434
On the use of corticosteroids for 2019-nCoV pneumoniaLancet, The2020399